Thushan I. de Silva - Concepedia

Author

Thushan I. de Silva

Also Known As

Alexander J Mentzer, Ana da Silva, Ana da Silva Filipe, Andrew A. Peden, Annemarie B Docherty, Banerjee Subhro-Osuji, Beatrice Alex, Clark D Russell, Cristina De Rose, Dawn Singleton

346

Publications

29.6K

Citations

H-Index

Concepts

All Affiliations

University of Sheffield University of Oxford Imperial College London Sheffield Teaching Hospitals NHS Foundation Trust University of Liverpool

About

Thushan I. de Silva is an author at University of Sheffield specializing in medicine, covid-19, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	4.5K
2	Public Health	9	9	562
3	Allergy	2	2	88
4	Engineering	1	1	20
5	Clinical Immunology	1	1	17

Thushan I. de Silva

133

Publications

16.7K

Citations

H-Index

Page 1

	Year	Citations
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus Bette Korber, Will Fischer, S. Gnanakaran, Cell	2020	4.4K
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Yanchun Peng, Alexander J. Mentzer, Guihai Liu, Nature Immunology	2020	1.4K
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Hall, Sarah Foulkes, André Charlett, The Lancet Long CovidSars-cov-2 Infection RatesCovid-19 PandemicInfection ControlAntibody-negative Health-care Workers	2021	732
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett, Joe Grove, Oscar A. MacLean, Nature Microbiology	2022	701
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Rachael A Evans, Hamish McAuley, Ewen M. Harrison, The Lancet Respiratory Medicine	2021	636
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 Bette Korber, WM Fischer, S. Gnanakaran, Real-time MutationViral PathogenesisImmunologyViral Structural ProteinVirus Transmission	2020	562
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Bo Meng, Steven A. Kemp, Guido Papa, Cell Reports	2021	446
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382

Page 1